Multifocal meningiomatosis: A case study highlighting diagnostic and monitoring challenges
Keywords:
meningioma, neuro-oncology, tumor, neuroradiology, MRI, CTAbstract
This case presentation discusses the diagnostic and monitoring challenges of a rare case of multifocal meningiomatosis in a 27-year-old female who initially presented with dizziness and migraine in 2019. Emergency CT revealed multiple formations with calcifications of extra-axial origin. Subsequent contrast-enhanced MRI exposed approximately 20 meningiomas in both cerebral and medullary locations. A comparison of MRI findings from 2019 to 2023 demonstrated an average growth of meningiomas from 3 to 5 mm. This case report emphasizes the crucial role of contrast-enhanced MRI in the diagnosis and monitoring of meningiomatosis, underscores the complexity of managing meningiomatosis and shows the importance of close clinical and radiological follow-up in determining the appropriate timing for intervention.
References
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010 Sep;99(3):307-14. doi: 10.1007/s11060-010-0386-3.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1
Kacemi IE, Miloudi G. Multiple meningiomatosis. Pan Afr Med J. 2021 Sep 24;40:59. doi: 10.11604/pamj.2021.40.59.30098
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006
Aizer AA, Bi WL, Kandola MS, et al. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015 Dec 15;121(24):4376-81. doi: 10.1002/cncr.29639.
Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015 Jan;122(1):4-23. doi: 10.3171/2014.7.JNS131644.
Ostrom QT, Gittleman H, Truitt G, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131.
Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T. Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging. 2014 Feb;5(1):113-22. doi: 10.1007/s13244-013-0302-4.
Loken EK, Huang RY. Advanced Meningioma Imaging. Neurosurg Clin N Am. 2023 Jul;34(3):335-345. doi: 10.1016/j.nec.2023.02.015
Tamrazi B, Shiroishi MS, Liu CS. Advanced Imaging of Intracranial Meningiomas. Neurosurg Clin N Am. 2016 Apr;27(2):137-43. doi: 10.1016/j.nec.2015.11.004.
Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol. 2004 Apr;63(4):275-86. doi: 10.1093/jnen/63.4.275.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1.
Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018 Mar;18(3):241-249. doi: 10.1080/14737175.2018.1429920.
Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004 May 8;363(9420):1535-43. doi: 10.1016/S0140-6736(04)16153-9.
Millward CP, Keshwara S, Islim AI, Zakaria R, Jenkinson MD. Clinical Presentation and Prognosis. Adv Exp Med Biol. 2023;1416:5-20. doi: 10.1007/978-3-031-29750-2_2.
Maggio I, Franceschi E, Tosoni A, et al. Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncol. 2021 Jun 1;10(2):CNS72. doi: 10.2217/cns-2021-0003
Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9.
Brastianos PK, Horowitz PM, Santagata S, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013 Mar;45(3):285-9. doi: 10.1038/ng.2526
Clark VE, Harmancı AS, Bai H, Youngblood MW, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016 Oct;48(10):1253-9. doi: 10.1038/ng.3651.
Gutman DA, Cooper LAD, Hwang SN, et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology. 2013 May;267(2):560-9. doi: 10.1148/radiol.13120118.
Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol. 2001 Jan;22(1):60-4.
Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg. 2011 May;114(5):1250-6. doi: 10.3171/2010.12.JNS101623.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Domenico Mannatrizio, Valentina Testini, Giacomo Fascia, Francesco Saverio Guerra, Federica Masino, Roberto Bellitti, Giuseppe Guglielmi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
